Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma 45Lymphoma, Large B-Cell, Diffuse 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Burkitt Lymphoma 22Neuroblastoma 20Leukemia 20Lymphoma, Non-Hodgkin 19Sarcoma 12Multiple Myeloma 12Lymphoma, Follicular 12Central Nervous System Neoplasms 12HIV Infections 11Hodgkin Disease 10Lymphoma, Large-Cell, Immunoblastic 9Acquired Immunodeficiency Syndrome 9Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Mantle-Cell 8Leukemia, Lymphocytic, Chronic, B-Cell 7Neuroectodermal Tumors, Primitive, Peripheral 6Neoplasms, Plasma Cell 6Lymphoma, Large-Cell, Anaplastic 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma, B-Cell 5Leukemia, Biphenotypic, Acute 5Sarcoma, Kaposi 4Sarcoma, Ewing 4Rhabdomyosarcoma 4Neoplasms 4Lymphoma, T-Cell 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

pevonedistat 1Vincristine 1Rituximab 1Prednisone 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Acromesomelic dysplasia, Maroteaux type × Vincristine × Clear all
NCT01415765 2019-12-17

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
LymphoidSarcoma

Acromesomelic dysplasia, Maroteaux type, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡